NDC Labeler Synergy Health Ast, Llc
Synergy Health Ast, Llc labeler's code is 71161. The labeler has 27 products that have an assigned National Drug Code.
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Product Type | Status |
---|---|---|---|---|---|---|
71161-103 | Triptorelin Pamoate | Injection, Powder, Lyophilized, For Suspension | Drug For Further Processing | UNFINISHED | ||
71161-104 | Triptorelin Pamoate | Injection, Powder, Lyophilized, For Suspension | Drug For Further Processing | UNFINISHED | ||
71161-105 | Triptorelin Pamoate | Injection, Powder, Lyophilized, For Suspension | Drug For Further Processing | UNFINISHED | ||
71161-106 | Triptorelin | Injection, Powder, Lyophilized, For Suspension | Drug For Further Processing | UNFINISHED | ||
71161-114 | Lanreotide Acetate | Injection | Drug For Further Processing | UNFINISHED | ||
71161-115 | Lanreotide Acetate | Injection | Drug For Further Processing | UNFINISHED | ||
71161-116 | Lanreotide Acetate | Injection | Drug For Further Processing | UNFINISHED | ||
71161-126 | Pasireotide | Injection, Powder, For Suspension | Drug For Further Processing | UNFINISHED | ||
71161-127 | Pasireotide | Injection, Powder, For Suspension | Drug For Further Processing | UNFINISHED | ||
71161-128 | Pasireotide | Injection, Powder, For Suspension | Drug For Further Processing | UNFINISHED | ||
71161-129 | Pasireotide | Injection, Powder, For Suspension | Drug For Further Processing | UNFINISHED | ||
71161-130 | Pasireotide | Injection, Powder, For Suspension | Drug For Further Processing | UNFINISHED | ||
71161-131 | Risperidone | Kit | Drug For Further Processing | UNFINISHED | ||
71161-132 | Risperidone | Kit | Drug For Further Processing | UNFINISHED | ||
71161-133 | Mometasone Furoate | Implant | Drug For Further Processing | UNFINISHED | ||
71161-134 | Fluocinolone Acetonide | Implant | Drug For Further Processing | UNFINISHED | ||
71161-135 | Triamcinolone Acetonide | Injection, Powder, For Suspension, Extended Release | Drug For Further Processing | UNFINISHED | ||
71161-138 | Dexamethasone | Implant | Drug For Further Processing | UNFINISHED | ||
71161-142 | Olanzapine Pamoate | Injection, Powder, For Suspension, Extended Release | Drug For Further Processing | UNFINISHED | ||
71161-143 | Olanzapine Pamoate | Injection, Powder, For Suspension, Extended Release | Drug For Further Processing | UNFINISHED | ||
71161-144 | Olanzapine Pamoate | Injection, Powder, For Suspension, Extended Release | Drug For Further Processing | UNFINISHED | ||
71161-146 | Afamelanotide | Implant | Drug For Further Processing | UNFINISHED | ||
71161-147 | Etonogestrel | Implant | Drug For Further Processing | UNFINISHED | ||
71161-148 | Talc | Powder | Drug For Further Processing | UNFINISHED | ||
71161-149 | Talc | Powder | Drug For Further Processing | UNFINISHED | ||
71161-150 | Talc | Powder | Drug For Further Processing | UNFINISHED | ||
71161-151 | Travoprost Intracameral | Implant | Drug For Further Processing | UNFINISHED |